92 related articles for article (PubMed ID: 18399001)
1. Caution regarding nelfinavir use in children and pregnant women.
AIDS Clin Care; 2007 Nov; 19(11):96. PubMed ID: 18399001
[TBL] [Abstract][Full Text] [Related]
2. Anti-HIV agents. Nelfinavir levels during pregnancy.
TreatmentUpdate; 2004; 16(3):5-6. PubMed ID: 17216835
[No Abstract] [Full Text] [Related]
3. Nelfinavir (Viracept).
Res Initiat Treat Action; 2000 Mar; 6(1):30-1. PubMed ID: 11708185
[No Abstract] [Full Text] [Related]
4. Symptomatic junctional bradycardia after treatment with nelfinavir.
Landovitz RJ; Sax PE
Clin Infect Dis; 1999 Aug; 29(2):449-50. PubMed ID: 10476763
[No Abstract] [Full Text] [Related]
5. Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death.
Hare CB; Vu MP; Grunfeld C; Lampiris HW
Clin Infect Dis; 2002 Nov; 35(10):e111-2. PubMed ID: 12410494
[TBL] [Abstract][Full Text] [Related]
6. Maintaining the nelfinavir trough concentration above 0.8 mg/L improves virologic response in HIV-1-infected children.
Burger DM; Bergshoeff AS; De Groot R; Gibb D; Walker S; Tréluyer JM; Hoetelmans RM;
J Pediatr; 2004 Sep; 145(3):403-5. PubMed ID: 15343199
[TBL] [Abstract][Full Text] [Related]
7. Caution with nelfinavir and some lipid-lowering drugs.
TreatmentUpdate; 2001; 13(7):2. PubMed ID: 11808505
[No Abstract] [Full Text] [Related]
8. Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Does Roche's nelfinavir cause less diarrhea?
TreatmentUpdate; 2003; 15(3):7. PubMed ID: 17216849
[No Abstract] [Full Text] [Related]
9. Decrease in methodone levels with nelfinavir mesylate.
McCance-Katz EF; Farber S; Selwyn PA; O'Connor A
Am J Psychiatry; 2000 Mar; 157(3):481. PubMed ID: 10698844
[No Abstract] [Full Text] [Related]
10. Nelfinavir in expanded postexposure prophylaxis causing acute hepatitis with cholestatic features: two case reports.
Trapé M; Barnosky S
Infect Control Hosp Epidemiol; 2001 Jun; 22(6):333-4. PubMed ID: 11519908
[No Abstract] [Full Text] [Related]
11. Nelfinavir-induced urticaria and successful desensitization.
Demoly P; Messaad D; Trylesinski A; Faucherre V; Fabre J; Reynes J; Delmas C; Dohin E; Godard P; Bousquet J
J Allergy Clin Immunol; 1998 Nov; 102(5):875-6. PubMed ID: 9819308
[No Abstract] [Full Text] [Related]
12. Nelfinavir associated with peripheral neuropathy in an HIV-infected patient.
Grunke M; Kraetsch HG; Löw P; Rascu A; Kalden JR; Harrer T
Infection; 1998; 26(4):252. PubMed ID: 9717687
[No Abstract] [Full Text] [Related]
13. Nelfinavir safe and effective in HIV/HCV patients.
AIDS Patient Care STDS; 2003 Nov; 17(11):602-3. PubMed ID: 14750219
[No Abstract] [Full Text] [Related]
14. Atazanavir demonstrates antiviral efficacy and a favorable lipid profile at 48 weeks.
J Assoc Nurses AIDS Care; 2002; 13(2):86-7. PubMed ID: 11936070
[No Abstract] [Full Text] [Related]
15. Nelfinavir tolerated in HCV patients.
AIDS Patient Care STDS; 2002 Dec; 16(12):617. PubMed ID: 12881882
[No Abstract] [Full Text] [Related]
16. Paronychia in an HIV-infected patient under nelfinavir therapy.
Domínguez MV; Ceballos VC; Costa RV; Lara TE; Florencio VD
J Eur Acad Dermatol Venereol; 2007 May; 21(5):710-1. PubMed ID: 17448006
[No Abstract] [Full Text] [Related]
17. Supplement fix for nelfinavir-related diarrhea.
TreatmentUpdate; 2002 Nov; 14(8):8. PubMed ID: 12501830
[No Abstract] [Full Text] [Related]
18. Biomedicine. HIV drug shows promise as potential cancer treatment.
Cohen J
Science; 2007 Sep; 317(5843):1305. PubMed ID: 17823319
[No Abstract] [Full Text] [Related]
19. Bone appetite--using food to boost your Viracept.
Clay PG
Posit Aware; 2003; 14(4):29. PubMed ID: 12951947
[No Abstract] [Full Text] [Related]
20. Recall of AIDS drug hits world's poorest patients.
AIDS Read; 2007 Sep; 17(9):439. PubMed ID: 17902224
[No Abstract] [Full Text] [Related]
[Next] [New Search]
